A: Many side effects overlap because both activate the GLP-1 receptor
Semaglutide works through several simultaneous mechanisms: it reduces appetite and food cravings, slows digestion so you feel full longer, improves insulin response, and may lower blood pressure and other cardiometabolic risk markers
Several mechanisms could theoretically contribute to altered skin sensation or sensitivity during semaglutide therapy, though these remain speculative without robust clinical evidence
Wegovy is typically prescribed for people who are looking for an effective obesity treatment and is recommended for individuals with a body mass index (BMI) of 27 or higher and who have at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol, according to the drugs Health Canada approval statement
Also, people with a low BMI or who havent tried other weight loss methods might not be good candidates